Eric W Fish

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. pmc Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine
    Eric W Fish
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Psychopharmacology (Berl) 220:719-30. 2012
  2. doi request reprint Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice
    Eric W Fish
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Alcohol Clin Exp Res 34:81-9. 2010
  3. pmc Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice
    J Elliott Robinson
    Laboratory of Developmental Neuropharmacology, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7025, USA
    Neuropsychopharmacology 38:1322-33. 2013
  4. pmc Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome
    Thorfinn T Riday
    Curriculum in Neurobiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina North Carolina 27599, USA
    J Clin Invest 122:4544-54. 2012
  5. pmc Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine
    J Elliott Robinson
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7025, USA
    Behav Brain Res 234:76-81. 2012
  6. pmc Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice
    Thorfinn T Riday
    Laboratory of Developmental Neuropharmacology, Department of Neurology, University of North Carolina at Chapel Hill, USA
    Brain Res 1431:53-61. 2012
  7. pmc Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice
    Eric W Fish
    aDepartment of Neurology bBowles Center for Alcohol Studies cNeurobiology, Curriculum University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Behav Pharmacol 25:61-70. 2014
  8. pmc Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome
    Eric W Fish
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
    PLoS ONE 8:e77896. 2013

Collaborators

Detail Information

Publications8

  1. pmc Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine
    Eric W Fish
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Psychopharmacology (Berl) 220:719-30. 2012
    ..Sensitivity to the stimulant and rewarding effects of alcohol may be genetically correlated traits that predispose individuals to develop an alcohol use disorder...
  2. doi request reprint Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice
    Eric W Fish
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Alcohol Clin Exp Res 34:81-9. 2010
    ..These experiments had 2 objectives: first, to establish the effects of alcohol on ICSS responding in the C57Bl6/J (C57) and DBA2/J (DBA) mouse strains; and second, to compare these effects to those of the psychostimulant cocaine...
  3. pmc Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice
    J Elliott Robinson
    Laboratory of Developmental Neuropharmacology, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7025, USA
    Neuropsychopharmacology 38:1322-33. 2013
    ..The opposite effects of LEV pretreatment on alcohol- and cocaine-related behaviors may predict its clinical utility in the treatment of patients with alcohol, but not psychostimulant abuse disorders...
  4. pmc Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome
    Thorfinn T Riday
    Curriculum in Neurobiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina North Carolina 27599, USA
    J Clin Invest 122:4544-54. 2012
    ..These findings demonstrate the complex effects of UBE3A loss on dopamine signaling in subcortical motor pathways that may inform ongoing clinical trials of L-DOPA therapy in patients with AS...
  5. pmc Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine
    J Elliott Robinson
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7025, USA
    Behav Brain Res 234:76-81. 2012
    ..Given the public health concern of stimulant abuse, future studies will be necessary to determine the cellular and behavioral effects of acute and chronic mephedrone use...
  6. pmc Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice
    Thorfinn T Riday
    Laboratory of Developmental Neuropharmacology, Department of Neurology, University of North Carolina at Chapel Hill, USA
    Brain Res 1431:53-61. 2012
    ..The data are discussed in the context of prior findings of SB 334867 effects on drug-seeking and drug-consuming behaviors...
  7. pmc Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice
    Eric W Fish
    aDepartment of Neurology bBowles Center for Alcohol Studies cNeurobiology, Curriculum University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Behav Pharmacol 25:61-70. 2014
    ..These effects appear specific to alcohol, as LEV did not affect sucrose intake in either experiment. LEV appears to differentially affect drinking in animal models of moderate and heavier alcohol consumption. ..
  8. pmc Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome
    Eric W Fish
    Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
    PLoS ONE 8:e77896. 2013
    ..Preclinical findings suggest that drugs acting through multiple neurotransmitter systems may be necessary to fully address abnormal behaviors in individuals with FXS. ..